Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 274 is a human protein encoded by the ZNF274 gene. It is characterized by the presence of five C2H2-type zinc finger domains, one or two Kruppel-associated box A (KRAB) domains, and a leucine-rich domain. ZNF274 serves primarily as a transcriptional repressor that localizes predominantly to the nucleolus. It functions by binding sequence-specifically to DNA, particularly at the 3’-end of zinc-finger coding genes, and recruits chromatin-modifying proteins such as SETDB1 and TRIM28/KAP1, facilitating transcriptional repression and the maintenance of heterochromatin marks like H3K9me3 at transcriptionally active regions. It has been implicated in the regulation of imprinted gene expression (notably relevant for Prader-Willi syndrome) and may influence chromatin organization and gene silencing in a context-dependent manner. Several transcript variants exist due to alternative splicing and polyadenylation. ZNF274 is not currently recognized as a therapeutic target for any approved drugs, nor as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 274 (ZNF274).